Renoprotective effects of the 21-aminosteroid U74389G in ischemia- reperfusion injury and cold storage preservation

Paul J. Garvin, Michael L. Niehoff, Sandra M. Robinson, Bhargav Mistry, Robert Esterl, Tracy Heisler, Connie Combs, Andrew Berson, Harvey Solomon, Luis Salinas-Madrigal

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Free radical mediated lipid peroxidation (LPO) has been implicated in the pathogenesis of ischemic-reperfusion injury (IRI). To address the renoprotective effect(s) of LPO inhibition, the efficacy of the 21 aminosteroid U74389G was evaluated in three IRI models. In Model 1 51 unilateral nephrectomized rats that underwent 60 min of warm ischemia followed by a 72-hr reperfusion interval were treated with the test vehicle only, or 3, 6, or 12 mg/kg of U74389G intravenously, 5 min pre- or postischemia. In Model 2 Sprague-Dawley rats underwent sham operation (n=9), or 45 min of warm ischemia and 10 min of reperfusion with U74389G (6 mg/kg; n=10) or test vehicle only (n=10) administered intravenously over 10 min beginning 5 min prior to clamp release. After reperfusion, LPO was determined by assay of snap frozen tissue for thiobarbituric acid (TBA) concentrations (nmol/g tissue weight). In Model 3 domestic lean maid pigs (14-18 kg) underwent left nephrectomy with 30 min of warm ischemia, Collins C-4 flush, and 24 hr of cold storage preservation. Heterotopic autotransplantation and immediate contralateral nephrectomy was then performed in Group A- nonischemic controls (n=4), Group B-ischemic controls (n=5), and Group C- U74389G (6 mg/kg) administered preischemia and at autotransplantation (n=5). In Model 1 maximal renoprotection was demonstrated with the 6 mg/kg dose of U74389G administered after ischemia (ischemic control 72-hr serum creatinine (Cr) = 8.01±1.1 mg% vs. 3.32±0.96 mg%; ischemic control creatinine clearance = 0.069±0.03 ml/min vs. 0.206±0.04 ml/min; P<0.05). In Model 2 TBA levels were significantly lower in U74389G treated animals (88.5±10.0 vs. ischemic controls = 296.8±81.4; P=0.02). In Model 3 graft survivals were 100%, 0%, and 60% respectively. Peak Cr and BUN (mg%) were significantly greater in Group C vs. Group A, (Group A Cr = 8.59±0.63 vs. Group C = 12.8±1.01; Group A BUN = 64.1±2.73 vs. Group C = 104.9±12.21)-however, by day 10, thee were no significant differences in renal function: (Group A Cr = 2.15±0.3 vs. Group C = 2.10±0.06; Group A BUN = 27.0±6.0 vs. Group C = 31.1±6.4). These results support the beneficial effects of LPO inhibitors in models of ischemia-reperfusion, as well as preservation/transplantation, and suggest that this renoprotection correlates with decreased membrane lipid peroxidation.

Original languageEnglish (US)
Pages (from-to)194-201
Number of pages8
JournalTransplantation
Volume63
Issue number2
DOIs
StatePublished - Jan 27 1997
Externally publishedYes

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Renoprotective effects of the 21-aminosteroid U74389G in ischemia- reperfusion injury and cold storage preservation'. Together they form a unique fingerprint.

Cite this